Parkinson's Disease (PD) is a progressive neurodegenerative disorder primarily affecting the motor system. Characterized by bradykinesia, rigidity, and resting tremors, PD presents a complex clinical picture that is often challenging to manage.
PD is the second most common neurodegenerative disorder, affecting approximately 1% of individuals over the age of 60. Risk factors include age, male gender, and exposure to certain environmental toxins. Genetic predisposition also plays a role, with several mutations identified.
PD is characterized by the loss of dopaminergic neurons in the substantia nigra, leading to an imbalance in the basal ganglia's output. The exact cause of this neuronal death remains unclear, but it is thought to involve a combination of genetic and environmental factors.
PD typically presents with resting tremor, bradykinesia, and rigidity. Non-motor symptoms such as depression, constipation, and cognitive impairment are also common. Diagnosis is primarily clinical, supported by response to dopaminergic therapy.
Management of PD is symptomatic, with levodopa being the most effective medication for motor symptoms. Non-pharmacological interventions, including physical therapy and deep brain stimulation, may also be beneficial. Regular follow-up is essential to monitor disease progression and adjust treatment accordingly.
PD is a chronic disease with a variable course. Most patients experience a gradual progression of symptoms over many years. Prognosis is influenced by age at onset, severity of symptoms, and response to treatment.
Understanding the complexities of PD is crucial for optimal patient management. As healthcare professionals, we must stay abreast of the latest research to provide the best possible care for our patients with PD.
1.
When does a melanoma metastasize? Implications for management
2.
Asandeutertinib Tops Osimertinib for NSCLC With Brain Mets
3.
Mammography with AI support is a secure method for detecting breast cancer.
4.
Compared to previous estimates, a greater number of patients participate in cancer treatment trials.
5.
The biology of cancer as well as potential treatment options are examined by experts.
1.
Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome
2.
HPV and Immunotherapy in Cancer Survivorship: National Cancer Survivors Day Review
3.
Tumor-Associated Stroma Regeneration Models
4.
Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025
5.
Immunotherapy Tolerance in Older Adults With Cancer
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation